United States · FDA National Drug Code directory
Lubiprostone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-906_2cbe759e-e896-7ada-e063-6394a90a6cc5
- Product NDC
- 76420-906
- Form
- CAPSULE, GELATIN COATED
- Composition / generic term
- lubiprostone
- Labeler
- Asclemed USA, Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20230101
- Source listing expiry
- 20261231
Source-listed ingredients
- LUBIPROSTONE — 8 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, GELATIN COATED in 1 BOTTLE (76420-906-01) · 76420-906-01
- 30 CAPSULE, GELATIN COATED in 1 BOTTLE (76420-906-30) · 76420-906-30
- 60 CAPSULE, GELATIN COATED in 1 BOTTLE (76420-906-60) · 76420-906-60
- 90 CAPSULE, GELATIN COATED in 1 BOTTLE (76420-906-90) · 76420-906-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →